Over the past decade, demand for innovative therapies, a large and diverse
patient population and favourable government initiatives have
transformed APAC into a preferred destination for conducting
clinical trials. According to Grand View Research, the APAC
clinical trials market was valued at USD 12.1 billion in 2024 and
is projected to grow at a compound annual growth rate (CAGR) of
approximately 8.4% from 2025 through to 2032.
The Journal for Clinical Studies has recently featured Linical In an article looking at how the Asia-Pacific (APAC) market has recently been transformed into one of the world's leading markets for clinical development. In this article written by Alison Cundari and Clareece West, we share key insights into country specific strengths, and what the future looks like in the APAC region.
This article is taken from The Journal for Clinical Studies November 2025 edition, Volume 17, Edition 2, Pages 10-14. © Senglobal Ltd